Atezolizumab

You have access
Clinical Utility of Tremelimumab/Durvalumab as First-line Treatment for Unresectable Hepatocellular Carcinoma: Serum Cytokine Profile Insights
KUNIHIDE MOHRI, HIDENARI NAGAI, TAKANORI MUKOZU, TEPPEI MATSUI, HIDEKI NAGUMO, NAOYUKI YOSHIMINE, KOJIRO KOBAYASHI, YU OGINO, NORITAKA WAKUI, KOICHI MOMIYAMA, KOJI HIGAI, TAKAHISA MATSUDA and YOSHINORI IGARASHI

Anticancer Research March 2026, 46 (3) 1545-1556; DOI: https://doi.org/10.21873/anticanres.18049
You have access
Second-line Treatment Strategy in Unresectable Hepatocellular Carcinoma After First-line Atezolizumab Plus Bevacizumab
KUNIHIDE MOHRI, HIDENARI NAGAI, TAKAHISA MATSUDA, YOSHINORI IGARASHI and KOJI HIGAI

Anticancer Research September 2024, 44 (9) 3919-3929; DOI: https://doi.org/10.21873/anticanres.17220
You have access
Comparison of Real-world Efficacy and Safety of Atezolizumab and Durvalumab in Combination With Chemotherapy for First-line Treatment of Extensive-stage Small-cell Lung Cancer
FUMIYASU IGATA, HIROYUKI INOUE, TAKATO IKEDA, AKIRA NAKAO, NORIYUKI EBI and MASAKI FUJITA

Anticancer Research July 2024, 44 (7) 3175-3183; DOI: https://doi.org/10.21873/anticanres.17132
You have access
Adverse Event Profile of Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel Combination Therapy Based on JADER
KIRI ENDO, HIROYUKI TANAKA, HAJIME MATSUO, TOSHIHISA ONODA, AYAKA IIDA and TOSHIHIRO ISHII

Anticancer Research June 2024, 44 (6) 2653-2660; DOI: https://doi.org/10.21873/anticanres.17072
You have access
Real Clinical Practice of Combined Atezolizumab Plus Chemotherapy in Patients With Small Cell Lung Cancer
SATOSHI ANO, NORIHIRO KIKUCHI, SHINICHIRO OKAUCHI, TAKESHI NUMATA, RYOTA NAKAMURA, TOSHIHIRO SHIOZAWA, HIROKO WATANABE, TOMOHIRO TAMURA, KUNIHIKO MIYAZAKI, SHIGEN HAYASHI, TAKAAKI YAMASHITA, KOICHI KURISHIMA, MASAHARU INAGAKI, TAKAYUKI KABURAGI, TAKEO ENDO, HIROAKI SATOH and NOBUYUKI HIZAWA

Anticancer Research June 2024, 44 (6) 2725-2730; DOI: https://doi.org/10.21873/anticanres.17080
You have access
Association Between Serum Magnesium Levels and Outcomes of Atezolizumab in Patients With Metastatic Urothelial Carcinoma
WATARU FUKUOKAYA, KOHEI AKAZAWA and TAKAHIRO KIMURA

Anticancer Research May 2024, 44 (5) 2117-2123; DOI: https://doi.org/10.21873/anticanres.17017
You have access
Atezolizumab for EGFR-mutated Non-small Cell Lung Cancer Patients: An Observation Study in Ibaraki Group (ATTENTION-IBARAKI)
TOMOHIRO TAMURA, TAKESHI NUMATA, HIDETOSHI YANAI, RYOTA NAKAMURA, TOSHIHIRO SHIOZAWA, HIROKO WATANABE, SHINICHIRO OKAUCHI, NORIHIRO KIKUCHI, KUNIHIKO MIYAZAKI, SHIGEN HAYASHI, TAKAAKI YAMASHITA, KOICHI KURISHIMA, MASAHARU INAGAKI, HIROAKI SATOH, HIROICHI ISHIKAWA, TAKAYUKI KABURAGI, TAKEO ENDO, TORU SAKAMOTO and NOBUYUKI HIZAWA

Anticancer Research October 2023, 43 (10) 4583-4591; DOI: https://doi.org/10.21873/anticanres.16652
You have access
Importance of Atezolizumab Plus Bevacizumab Combination Treatment as First-line Therapy for Immunological Changes in Patients With Unresectable Hepatocellular Carcinoma
KOJIRO KOBAYASHI, HIDENARI NAGAI, TEPPEI MATSUI, TAKAHISA MATSUDA and KOJI HIGAI

Anticancer Research October 2023, 43 (10) 4601-4609; DOI: https://doi.org/10.21873/anticanres.16654
Open Access
Atezolizumab Retains Cellular Binding to Programmed Death Ligand 1 Following Aerosolization via Mesh Nebulizer
GINTARAS ZALESKIS, MARTYNAS TALAIKIS, DAINIUS CHARACIEJUS, VINCAS URBONAS, PAULIUS BOSAS, ADAS DARINSKAS, LAVIJA ZIBUTYTE, LUKAS SIMKUS, ZILVINAS SURVILA, JURGITA JURSENAITE and MARGARITA ZVIRBLE

Anticancer Research March 2023, 43 (3) 1065-1072; DOI: https://doi.org/10.21873/anticanres.16251
You have access
First-line Chemotherapy Response Is Associated With Clinical Outcome During Immune Checkpoint Inhibitor Treatment in Advanced Urothelial Carcinoma: A Real World Retrospective Study
JIAN-RI LI, SHIAN-SHIANG WANG, KEVIN LU, CHAUN-SHU CHEN, CHEN-LI CHENG, SHENG-CHUN HUNG, KUN-YUAN CHIU, CHIANN YI HSU and CHENG-KUANG YANG

Anticancer Research March 2023, 43 (3) 1331-1339; DOI: https://doi.org/10.21873/anticanres.16281

Main menu

User menu

Search

Atezolizumab

Pages